Corlieve Therapeutics (private company)

See something wrong or missing? Let us know
Offices:Paris
Business model:B2B

Corlieve Therapeutics develops first and best in class medicines for specific neuronal targets that have the potential to transform patients’ lives.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Corlieve Therapeutics

Name Criteria
United Kingdom Achilles Therapeutics
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Norway APIM Therapeutics
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Sweden Aprea Therapeutics
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Germany Atai Life Sciences
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
United Kingdom Biofidelity
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Sweden BoneSupport
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Germany CatalYm
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Sweden Elypta
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Denmark Galecto Biotech
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
France InnovaFeed SAS
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Top